Literature DB >> 9302746

Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties.

N Goto1, H Kato, J Maeyama, M Shibano, T Saito, J Yamaguchi, S Yoshihara.   

Abstract

Effects of calcium phosphate and aluminium hydroxide adjuvants with different physical properties were examined in guinea pigs for local histopathological reactions, electron-microscopical changes of macrophages and adjuvanticity on total IgG antibody response to subcutaneously administered ovalbumin (OVA) and tetanus toxoid (TT). Calcium phosphate gel (Ca-gel) induced active inflammatory reactions consisting of neutrophils (pseudoeosinophils) and foamy macrophages associated with many multinuclear giant cells for at least 4 weeks. Aluminium hydroxide gel (Al-gel) also elicited granulomatous inflammatory reactions consisting mainly of macrophages with foamy cytoplasm, small lymphocytes and giant cells at the injection sites for up to 8 weeks or longer. Severity of local tissue irritation due to calcium phosphate gel (Ca-gel) was similar to that due to Al-gel except for the duration of the inflammatory reactions. Calcium phosphate suspension (Ca-sus)-induced local reactions completely ceased by the 4th week, while aluminium hydroxide suspension (Al-sus)-induced reactions were seen up to the 8th week. Electron-microscopical observations showed that both Al-gel and Al-sus caused damage of macrophages. The adjuvant activity of Al-gel for OVA or TT was significantly stronger than that of any other adjuvant material, whereas those of Ca-gel and Ca-sus were not seen at a dose of 3 mg calcium phosphate per millilitre. Al-sus-TT at a dose of 3 mg aluminium hydroxide per millilitre induced very low levels of antibody. These results suggest that calcium phosphate adjuvant may not be an useful alternative to Al adjuvant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302746     DOI: 10.1016/s0264-410x(97)00054-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

Review 1.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 3.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009

Review 4.  Hypothesis driven development of new adjuvants: short peptides as immunomodulators.

Authors:  Jessica C Dong; Gary P Kobinger
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

5.  Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.

Authors:  Hong Zheng; Yun Hu; Wei Huang; Sabina de Villiers; Paul Pentel; Jianfei Zhang; Harry Dorn; Marion Ehrich; Chenming Zhang
Journal:  J Biomed Nanotechnol       Date:  2015-12       Impact factor: 4.099

Review 6.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

7.  DNA released from dying host cells mediates aluminum adjuvant activity.

Authors:  Thomas Marichal; Keiichi Ohata; Denis Bedoret; Claire Mesnil; Catherine Sabatel; Kouji Kobiyama; Pierre Lekeux; Cevayir Coban; Shizuo Akira; Ken J Ishii; Fabrice Bureau; Christophe J Desmet
Journal:  Nat Med       Date:  2011-07-17       Impact factor: 53.440

8.  Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2.

Authors:  Qing He; Alaina Mitchell; Tulin Morcol; Steve J D Bell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism.

Authors:  M Ulanova; A Tarkowski; M Hahn-Zoric; L A Hanson
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Comparison of adjuvant and adjuvant-free murine experimental asthma models.

Authors:  M L Conrad; A O Yildirim; S S Sonar; A Kiliç; S Sudowe; M Lunow; R Teich; H Renz; H Garn
Journal:  Clin Exp Allergy       Date:  2009-05-03       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.